Literature DB >> 10462020

Should use of the internal thoracic artery be avoided under conditions of low free flow? Postoperative hemodynamic assessment using pulsed Doppler echocardiography.

M Hata1, M Shiono, Y Orime, H Hata, S Yagi, T Yamamoto, S Tsukamoto, H Okumura, S Kimura, A Sezai, S Kashiwazaki, S Choh, N Negishi, Y Sezai, N Tanigawa, A Shindoh.   

Abstract

There are cases in which it is thought advisable to avoid the use of the left internal thoracic artery (LITA) in coronary artery bypass grafting (CABG) due to its low free flow (FF). However, even though the LITA flow is very low, anastomosis without any further maneuvers intraluminally is recommended. The present study investigated the clinical results of CABG, using a LITA with low FF. The 60 cases of CABG were divided into 2 groups: (i) Group L (n = 23), in which LITA FF was less than 20 ml/min; and (ii) Group H (n = 37) in which it was more than 20 ml/min. A comparative study on the basis of coronary angiography and pulsed Doppler echocardiography was performed. In both groups, no LITA graft occlusion was identified, and the 'string sign' was also absent. In the LITA blood waveform, all cases exhibited a biphasic pattern with a higher mid-diastolic and a lower end-systolic component. There were no significant differences in the LITA flow diastolic peak velocity, velocity time integrals and the diastolic/systolic peak velocity ratios. These results suggest that the LITA can be used for CABG even when the free flow is less than 20 ml/min.

Entities:  

Mesh:

Year:  1999        PMID: 10462020     DOI: 10.1253/jcj.63.533

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  1 in total

1.  Evaluation of flow characteristics of the left internal thoracic artery graft: perioperative color Doppler ultrasonography versus intraoperative free-bleeding technique.

Authors:  Kerim Cagli; Mustafa Emir; Aysegul Kunt; Kumral Ergun; Tola Muharrem; Topbas Murat; Kerem Vural; Erol Sener
Journal:  Tex Heart Inst J       Date:  2004
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.